My watch list
my.bionity.com  
Login  

Thermo Fisher Scientific to Acquire Advanced Bioprocessing Business from BD

14-Sep-2018

Thermo Fisher Scientific Inc. has signed a definitive agreement with BD (Becton, Dickinson and Compan), under which Thermo Fisher will acquire BD's Advanced Bioprocessing business. This business combines a strong technical services program with a variety of peptones that enhance cell culture media formulations to improve yield and reduce variability in biopharmaceutical applications.

"Thermo Fisher has a trusted value proposition for customers who are working in biologic drug development and manufacturing," said Mark Stevenson, executive vice president and chief operating officer of Thermo Fisher Scientific. "The addition of these new capabilities will complement our bioproduction offering and strengthen our ability to serve this rapidly growing market, from development to large-scale production."

Patrick Kaltenbach, president of Life Sciences for BD, said "We are excited that our Advanced Bioprocessing team will have the opportunity to join a company with deep expertise and a long-standing commitment to supporting biopharmaceutical production. It will create new prospects, building on a 25-year history of ensuring that high-quality biopharmaceuticals get to the market quickly."

BD's Advanced Bioprocessing business has annualized revenue of approximately $100 million and will be integrated into Thermo Fisher's Life Sciences Solutions Segment.

The transaction is subject to customary closing conditions and is expected to close in early 2019.

Facts, background information, dossiers
  • BD
  • acquisitions
  • peptones
More about Thermo Fisher Scientific
More about BD
  • News

    Corning Completes BD Discovery Labware Business Acquisition

    Corning Incorporated announced that it has completed the previously announced acquisition of the majority of the Discovery Labware business from BD (Becton, Dickinson and Company) for approximately $720 million in cash.The acquisition of the BD Discovery Labware business will expand Corning ... more

    Corning to Acquire Majority of BD Discovery Labware

    Corning Incorporated announced that it has reached a definitive agreement with BD(Becton, Dickinson and Company) (NYSE:BDX) to acquire the majority of its Discovery Labware unit for approximately $730 million in cash. The acquisition is expected to be completed later this year, subject to c ... more

    BD Biosciences Announces Winners of Research Grant Program

    BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced today the latest round of winners of its Research Grant Program. “By awarding grants to these promising scientists, BD Biosciences continues to support innovative biomedical research across the United States,” said ... more

  • Companies

    Becton, Dickinson and Company

    BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious di ... more

    Becton, Dickinson and Company

    BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious di ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE